ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Sufentanil Citrate Injection shortage

Current  4 presentations · 2 manufacturers · first FDA posting 2022-05-03 · last update 2026-10-14

Manufacturers: Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company

Stated reasons (per FDA): Other

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 OtherNot currently manufacturedPosted 05/03/2022
Updated 10/14/2026
Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 OtherNot currently manufacturedPosted 05/03/2022
Updated 10/14/2026
Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)Hikma Pharmaceuticals USA, Inc.Current
Unavailable
 OtherNot currently manufacturedPosted 05/03/2022
Updated 10/14/2026
Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)Hospira, Inc., a Pfizer CompanyCurrent
Available
 —Posted 05/03/2022
Updated 10/08/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)